loading page

Rapid visual detection of Enterocytozoon hepatopenaei by recombinase polymerase amplification combined with a lateral flow dipstick
  • +4
  • Jianhu Pang,
  • Caiyuan Zhao,
  • Zhongcheng Liu,
  • Qiang Lu,
  • Xinyi He,
  • Shaoping Weng,
  • * Jianguo
Jianhu Pang
Sun Yat-sen University School of Life Science

Corresponding Author:[email protected]

Author Profile
Caiyuan Zhao
School of Marine Sciences Sun Yat-sen University Zhuhai 519000 PR China
Author Profile
Zhongcheng Liu
Sun Yat-sen University School of Life Science
Author Profile
Qiang Lu
Sun Yat-sen University School of Life Science
Author Profile
Xinyi He
Sun Yat-sen University School of Life Science
Author Profile
Shaoping Weng
Sun Yat-sen University School of Life Science
Author Profile
* Jianguo
Sun Yat-sen University School of Life Science
Author Profile

Abstract

Enterocytozoon hepatopenaei (EHP) is a high-impact pathogen in shrimp farming, causing huge economic losses to the global shrimp farming industry every year. However, current EHP detection methods are primarily based on the development of polymerase chain reaction (PCR) techniques that rely on sophisticated and expensive instruments. Consequently, a rapid, practical, and sensitive protocol for the detection of EHP is necessary. Recombinase polymerase amplification combined with a lateral flow dipstick (LFD-RPA) assay was developed using a pair of primers and nfo-probe targeting the conserved region of the spore wall protein gene. Under optimized reaction conditions, the LFD-RPA assay can detect 10 copies/μL of standard plasmid within 20 min at 40°C. Furthermore, this assay cannot amplify DNA from other shrimp pathogens. Thirty-nine samples of Litopenaeus vannamei were collected in shrimp farms and detected using LFD-RPA and nested PCR. Thirty-two positive samples were detected by LFD-RPA. Compared with those of nested PCR (32/39), the diagnostic sensitivity and specificity of LFD-RPA were 100% and 100%, respectively. These results indicated the great application potential of the newly developed LFD-RPA assay for point-of-care diagnosis, epidemic surveillance, and epidemiological investigation of EHP.
16 Sep 2022Published in Frontiers in Marine Science volume 9. 10.3389/fmars.2022.985314